Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
MedPage Today on MSN
Add-On Multicancer Early Detection Test Promising Across Various Cancer Types
BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...
The researchers argue that the integration of explainable AI into clinical decision-making pipelines could reshape cancer ...
When cancer spreads, tiny amounts of cells can break away from tumors and circulate in the bloodstream. A liquid biopsy is a ...
Oral cancer remains a serious health concern, often diagnosed too late for effective treatment, even though the mouth is ...
Affinity Technologies, Inc. ( ($BIAF) ) has issued an update. On October 16, 2025, bioAffinity Technologies, Inc. announced it received a ...
Oncology-focused biotech company Guardant Health is partnering with AI drug development company Zephyr AI to combine AI and ...
His nose is so powerful, it's used to sniff out cancer. Using the beagles' remarkable sense of smell, health startup ...
Worcester Telegram on MSNOpinion
Opinion/Guest column: More access to cancer tests, more lives saved
If Congress can rise above partisanship and make cancer screening tools accessible for seniors, lives can be saved.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback